On Wednesday 6th January 2021, the European Medicines Agency, EMA recommended Moderna’s COVID-19 vaccine for conditional market authorisation.
This was done following an extraordinary meeting, which at first was scheduled on the 12th of January, but due to the pressure done by the EU member states, the agency met on Wednesday 6th January.
Later on, the European Commission approved this recommendation, which means that now the European Union has the second vaccine available, together with BioNTech and Pfizer’s COVID-19 vaccine. The latter was recommended by the EMA and approved by the European Commission on the 21st of December 2020.
In a statement on Twitter, the European Commission President Ursula von der Leyer stated that so far Europe secured 2 billion doses of potential vaccines to protect us all.